Related Experiment Video
Updated: Jun 21, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Successful management of MRSA sepsis in a patient with left ventricular assist device
I Alejnik1, J Hoffmann, H H Scheld
1Department of Thoracic and Cardiovascular Surgery, Hospital of the University of Münster, Münster, Germany. sinderm@uni-muenster.de
Abstract:
Left ventricular assist devices (LVADs) offer the opportunity to substantially improve the clinical conditions and to interrupt hospitalization of patients suffering from end-stage heart failure awaiting heart transplantation. The authors report a case of a 66-year old patient suffering from end-stage idiopathic dilative cardiomyopathy who needed the implantation of a LVAD and later developed a sepsis with a methicillin resistant Staphylococcus aureus (MRSA) which could be recovered by a differentiated antibiotic regimen.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Mitral Stenosis III: Medical Management
Endocarditis III: Medical Management
Mitral Stenosis IV: Nursing Management
Endocarditis IV: Nursing Management
Clinical Significance of Antibiotic Resistance